Invest2018-10-25T11:57:35+00:00

Meta-IQ is an innovative Danish Biotech  company developing innovative treatments for Secondary progressive multiple sclerosis ( SP-MS).

Meta-IQ is preparing to raise the necessary funding to take the compound MIQ-001 through phase 2.

If you are interested in hearing more about the company or projects or are interested in joining the investment round then please contact us.

Contact

Søren Nielsen, CEO

E: sn@meta-iq.com

P: + 45 25 39 41 37


Martin G. Kloth, CFO

E: martin.kloth@meta-iq.com

P: +45 21 35 56 80

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close